These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25010828)

  • 41. KSHV MicroRNAs Repress Tropomyosin 1 and Increase Anchorage-Independent Growth and Endothelial Tube Formation.
    Kieffer-Kwon P; Happel C; Uldrick TS; Ramalingam D; Ziegelbauer JM
    PLoS One; 2015; 10(8):e0135560. PubMed ID: 26263384
    [TBL] [Abstract][Full Text] [Related]  

  • 42. De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells.
    Lagunoff M; Bechtel J; Venetsanakos E; Roy AM; Abbey N; Herndier B; McMahon M; Ganem D
    J Virol; 2002 Mar; 76(5):2440-8. PubMed ID: 11836422
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
    Smith CG; Kharkwal H; Wilson DW
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipid rafts of primary endothelial cells are essential for Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-induced phosphatidylinositol 3-kinase and RhoA-GTPases critical for microtubule dynamics and nuclear delivery of viral DNA but dispensable for binding and entry.
    Raghu H; Sharma-Walia N; Veettil MV; Sadagopan S; Caballero A; Sivakumar R; Varga L; Bottero V; Chandran B
    J Virol; 2007 Aug; 81(15):7941-59. PubMed ID: 17507466
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
    Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
    J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ.
    Zhang L; Zhu C; Guo Y; Wei F; Lu J; Qin J; Banerjee S; Wang J; Shang H; Verma SC; Yuan Z; Robertson ES; Cai Q
    J Virol; 2014 Jun; 88(12):6873-84. PubMed ID: 24696491
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphoma.
    Jiang Y; Xu D; Zhao Y; Zhang L
    PLoS One; 2008 Feb; 3(2):e1569. PubMed ID: 18253508
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FUS Negatively Regulates Kaposi's Sarcoma-Associated Herpesvirus Gene Expression.
    Dunker W; Song Y; Zhao Y; Karijolich J
    Viruses; 2018 Jul; 10(7):. PubMed ID: 29986386
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ets-1 is required for the activation of VEGFR3 during latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.
    Gutierrez KD; Morris VA; Wu D; Barcy S; Lagunoff M
    J Virol; 2013 Jun; 87(12):6758-68. PubMed ID: 23552426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus.
    King CA; Li X; Barbachano-Guerrero A; Bhaduri-McIntosh S
    J Virol; 2015 Nov; 89(22):11347-55. PubMed ID: 26339061
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kaposi's sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: a novel mechanism of virus control of latency.
    Ye FC; Zhou FC; Xie JP; Kang T; Greene W; Kuhne K; Lei XF; Li QH; Gao SJ
    J Virol; 2008 May; 82(9):4235-49. PubMed ID: 18305042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures.
    Ciufo DM; Cannon JS; Poole LJ; Wu FY; Murray P; Ambinder RF; Hayward GS
    J Virol; 2001 Jun; 75(12):5614-26. PubMed ID: 11356969
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Kaposi's sarcoma-associated herpesvirus microRNA and its variants target the transforming growth factor β pathway to promote cell survival.
    Lei X; Zhu Y; Jones T; Bai Z; Huang Y; Gao SJ
    J Virol; 2012 Nov; 86(21):11698-711. PubMed ID: 22915806
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells.
    Cannon M; Philpott NJ; Cesarman E
    J Virol; 2003 Jan; 77(1):57-67. PubMed ID: 12477810
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multi-targeted therapy of everolimus in Kaposi's sarcoma associated herpes virus infected primary effusion lymphoma.
    Mohanty S; Kumar A; Das P; Sahu SK; Choudhuri T
    Apoptosis; 2017 Sep; 22(9):1098-1115. PubMed ID: 28653223
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miRNAs and their roles in KSHV pathogenesis.
    Hussein HAM; Alfhili MA; Pakala P; Simon S; Hussain J; McCubrey JA; Akula SM
    Virus Res; 2019 Jun; 266():15-24. PubMed ID: 30951791
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression.
    Sharma-Walia N; Raghu H; Sadagopan S; Sivakumar R; Veettil MV; Naranatt PP; Smith MM; Chandran B
    J Virol; 2006 Jul; 80(13):6534-52. PubMed ID: 16775340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sphingosine kinase-2 is overexpressed in large granular lymphocyte leukaemia and promotes survival through Mcl-1.
    LeBlanc FR; Pearson JM; Tan SF; Cheon H; Xing JC; Dunton W; Feith DJ; Loughran TP
    Br J Haematol; 2020 Aug; 190(3):405-417. PubMed ID: 32124438
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
    Chang PJ; Chen LW; Chen LY; Hung CH; Shih YJ; Wang SS
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701396
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
    Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
    J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.